Study the risk of colorectal adenomas in patients detected with duodenal adenomas.
ID
Source
Brief title
Condition
- Benign neoplasms gastrointestinal
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The risk of colonic adenomas is calculated.
The risk of colonic adenomas in the study group is compared with a group of
patients screened for livertransplantation with gastroduodenoscopy and
colonoscopy in the same period. In this control group patients are excluded
with a disease with an increased risk of coloncancer (i.e. Primary biliairy
cholangitis).
Secondary outcome
no secundary parameters
Background summary
Colorectal cancer is the third most common cancer and the second most common
cause of cancer related deaths. Most cases of colon cancer begin as small
adenomatous polyps. Through colonoscopic examinations these adenomas can be
detected and subsequently removed. It is generally accepted that, like
colorectal adenomas, duodenal adenomas also follow the adenoma-carcinoma
sequence. Curiously, despite numerous phenotypic similarities between the small
and large intestinal epithelia, including a very high cellular turnover, small
intestinal neoplasia is very rare compared with its colorectal counterpart [1].
In the known hereditary colon cancer syndromes, patients are at increased risk
of small bowel adenomatosis/cancer besides their generally high risk of
colorectal adenomas/cancer. For instance, in 40-90% of patients with familial
adenomatous polyposis (FAP) duodenal adenomatosis is found (2-6). These
adenomas are mainly situated around the ampulla Vateri. The lifetime risk of
developing duodenal cancer in FAP is 3-4% at the age of 70 (7). Most polyposis
patients develop hundreds of colorectal adenomas and without prophylactic
colectomy they inevitably develop colon cancer (8). Also in other hereditary
colon cancer syndromes (MUTYH-associated polyposis and hereditary non-polyposis
colorectal cancer) gene carriers have an increased risk of small bowel
adenomas/cancer besides their high risk of colonic adenomas/cancer.
Sporadic duodenal adenoma is an uncommon finding. In a large Scandinavian study
only 0.4% of 584 endoscopy patients had duodenal polyps, of which 7% were
adenomatous [9]. Most adenomas are found incidentally at endoscopy. To date, it
is unknown whether this group of patients is, like gene carriers in the
hereditary colon cancer syndromes, at increased risk of colorectal adenomas.
Several retrospective studies suggest an increased risk of colorectal neoplasia
in patients with duodenal adenomas. In a recent study, 73% of patients with
duodenal adenomas and without familial adenomatous polyposis had colonic
adenomas [11-13]. Also small intestinal carcinoma is associated with
colorectal carcinoma and vice versa [10]. However, the extent to which duodenal
adenomas are associated with colorectal adenomas is not well prospectively
studied.
In conclusion, an increased risk of colonic adenomas (and thus of colon cancer)
in patients with duodenal adenomas is likely. Therefore, the risk of colonic
adenomas in this group of patients should be calculated in order to advise
these patients whether they should undergo endoscopic examinations of their
colon. Because duodenal adenomas are an uncommon finding, a multicenter trial
should answer this question.
References
1) Arber N, Neugut Aj, Weinstein IB, et al. Molecular genetics of small bowel
cancer. Cancer Epidemiol Biomarkers Prev 1997;6:745-8.
2) Alexander JR, Andrews JM, Buchi KN, Lee RG, Becker JM, Burt RW. High
prevalence of adenomatous polyps of the duodenal papilla in familial
adenomatous polyposis. Dig Dis Sci 1989; 34(2):167-170.
3) Bulow S, Lauritsen KB, Johansen A, Svendsen LB, Sondergaard JO.
Gastroduodenal polyps in familial polyposis coli. Dis Colon Rectum 1985;
28(2):90-93.
4) Burt RW, Berenson MM, Lee RG, Tolman KG, Freston JW, Gardner EJ. Upper
gastrointestinal polyps in Gardner's syndrome. Gastroenterology 1984;
86(2):295-301.
5) Church JM, McGannon E, Hull-Boiner S, Sivak MV, Stolk R van, Jagelman DG, et
al. Gastroduodenal polyps in patients with familial adenomatous polyposis. Dis
Colon Rectum 1992;35:1170-3.
6) Jarvinen H, Nyberg M, Peltokallio P, Upper gastrointestinal tract polyps in
familial adenomatosis coli. Gut 1983;24:333-9.
7) Vasen HF, Bulow S, Myrhoj T, Griffioen G, Buskens E, Taal BG et al. Decision
analysis in the management of duodenal adenomatosis in familial adenomatous
polyposis. Gut 1997; 40(6):716-719.
8) Bulow S, Burn J, Neale K, Northover J, Vasen H. The establishment of a
polyposis register. Int J Colorectal Dis 1993; 8:34-8.
9) Jespen JM, Persson M, Jakobsen NO, et al. Prospective study of prevalence
and endoscopic and histopathologic characteristics of duodenal polyps in
patients submitted to upper endoscopy. Scand J Gastroenterology 1994;29:483-7.
10) Neugut AL, Santos J. The association between cancers of the small and large
bowel. Cancer Epidemiol Biomartkers Prev 1993;2:551-3.
11) Murray MA, Zimmerman MJ, Ee HC, Sporadic duodenal adenoma is associated
with colorectal neoplasia. Gut 2004;53:261-265.
12) Apel D, Jakobs R, Weickert U, Riemann JF. High frequency of colorectal
adenoma in patients with duodenal adenoma but without familial adenomatous
polyposis.
Gasrointestinal Endoscopy 2004; 60: 397-9.
13) Ramsoekh D, Van Leerdam ME, Ouwendijk RJTh, Kuipers EJ. Sporadic duodenal
adenoma and colorectal neoplasia. (Abstract NVGE 6/10/2006)
Study objective
Study the risk of colorectal adenomas in patients detected with duodenal
adenomas.
Study design
Prospectively collected data in three hospitals (Slotervaart Hospital
Amsterdam, University Medical Center Groningen, Leiden University Medical
Center).
Study burden and risks
If during colonoscopy polyps are detected, they will be removed if possible. If
a polyp is removed there is a small chance of bleeding or perforation. The
estimated risk of a compication is about 0.2%.
Albinusdreef 2
2333 ZA Leiden
NL
Albinusdreef 2
2333 ZA Leiden
NL
Listed location countries
Age
Inclusion criteria
Patient with a by chance detected duodenal adenoma during upper gastrointestinal endoscopy.
Exclusion criteria
1) Patients known with familial adenomatous polyposis.
2) Patients known with MUTYH-associated polyposis coli.
3) Patients known with hereditary non polyposis colorectal cancer
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL14980.058.07 |